Literature DB >> 21186394

Trifunctional 99mTc based radiopharmaceuticals: metal-mediated conjugation of a peptide with a nucleus targeting intercalator.

Karel Zelenka1, Lubor Borsig, Roger Alberto.   

Abstract

The development of molecular imaging agents with multiple functions has become a major trend in radiopharmaceutical chemistry. We present herein the syntheses of trifunctional compounds, combining an acridine orange (AO) based intercalator with a GRP receptor specific bombesin like peptide (BBN). Metal-mediated conjugation of these two functions via the [2 + 1] approach to the third function, the [M(CO)(3)](+) (M = (99m)Tc, Re) moiety, yielded the final trifunctional molecules. The strongly fluorescent acridine orange, a nuclear targeting agent, has been derivatised with 4-imidazolecarboxylate as a bidentate ligand and bombesin with an isonitrile group as a monodentate ligand. For cell and nuclear uptake studies, [Re(L(1)-BBN)(L(2)-Ical)(CO)(3)] type complexes were synthesized and characterized. For radiopharmaceutical purposes, the (99m)Tc analogues have been prepared in a stepwise synthesis. Fluorescence microscopy studies on PC-3 cells, bearing the BBN receptor, showed high and rapid uptake into the cytoplasm. For the bifunctional molecule, lacking the BBN peptide, no internalization was observed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21186394     DOI: 10.1039/c0ob00504e

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Nuclear targeting with cell-specific multifunctional tricarbonyl M(I) (M is Re, (99m)Tc) complexes: synthesis, characterization, and cell studies.

Authors:  Teresa Esteves; Fernanda Marques; António Paulo; José Rino; Prasant Nanda; C Jeffrey Smith; Isabel Santos
Journal:  J Biol Inorg Chem       Date:  2011-06-25       Impact factor: 3.358

2.  Bromelain-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Formulation, Chemical Structure and Antiproliferative Effect Against Human Breast Cancer Cells (MCF-7).

Authors:  Catiúscia P Oliveira; Willian A Prado; Vladimir Lavayen; Sabrina L Büttenbender; Aline Beckenkamp; Bruna S Martins; Diogo S Lüdtke; Leandra F Campo; Fabiano S Rodembusch; Andréia Buffon; Adalberto Pessoa; Silvia S Guterres; Adriana R Pohlmann
Journal:  Pharm Res       Date:  2016-12-15       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.